{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ATX.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ATX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATX.AU\",,,,,undefined,":{"symbol":"ATX.AU","market":"AU","secType":"STK","nameCN":"AMPLIA THERAPEUTICS LTD","latestPrice":0.245,"timestamp":1774588320000,"preClose":0.23,"halted":0,"volume":14816196,"delay":0,"changeRate":0.06521739130434775,"nameEN":"AMPLIA THERAPEUTICS LTD","floatShares":351321835,"shares":513071629,"eps":-0.020164,"marketStatus":"休市中","change":0.015,"latestTime":"03-27 16:12:00 AEDT","open":0.22,"high":0.267,"low":0.22,"amount":3728937,"amplitude":0.204348,"askPrice":0.25,"askSize":40049,"bidPrice":0.24,"bidSize":283976,"shortable":3,"etf":0,"ttmEps":-0.020164,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1774825200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.23,"openAndCloseTimeList":[[1774566000000,1774587600000]],"volumeRatio":0.6403512964975189,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ATX.AU","preClose":0.23,"auctionPrice":0.245,"auctionVolume":345618,"auction":3,"marketStatus":"盘后竞价","timestamp":1774588205614}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ATX.AU\",,,,,undefined,":{"symbol":"ATX.AU","floatShares":351321835,"roa":"-17.71%","roe":"-28.49%","lyrEps":-0.021392,"volumeRatio":0.6403512964975189,"shares":513071629,"dividePrice":0,"high":0.267,"amplitude":0.204348,"preClose":0.23,"low":0.22,"week52Low":0.049,"pbRate":"2.93","psRate":"25.10","week52High":0.425,"institutionHeld":0,"latestPrice":0.245,"committee":0.752803,"eps":-0.020164,"divideRate":0,"volume":14816196,"delay":0,"ttmEps":-0.020164,"open":0.22,"prevYearClose":0.15,"prevWeekClose":0.112,"prevMonthClose":0.12,"prevQuarterClose":0.15,"fiveDayClose":0.112,"twentyDayClose":0.12,"sixtyDayClose":0.15,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-04-18","symbol":"ATX.AU","defaultRemindTime":1713398400000,"type":"split","dateTimestamp":1713362400000,"forFactor":971896,"toFactor":1000000,"ratio":0.971896}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATX.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1113965610","title":"Amplia Therapeutics胰腺癌试验再获四例完全缓解 总体生存数据持续改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1113965610","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113965610?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 20:45","pubTimestamp":1774269918,"startTime":"0","endTime":"0","summary":"生物制药企业AmplIA THERAPEUTICS LTD最新临床数据显示，其针对胰腺癌的ACCENT试验取得突破性进展。该研究在原有成果基础上新增四例完全缓解病例，同时患者总体生存期呈现显著延长趋势。此次数据更新进一步验证了候选药物在晚期胰腺癌治疗领域的潜力，为后续研发提供重要临床依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ATX.AU"],"gpt_icon":0},{"id":"1115223185","title":"Amplia与韩国专业药物筛选公司Next&Bio签署第二项协议，探索Fak抑制剂与Kras抑制剂的联合治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1115223185","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115223185?lang=zh_cn&edition=fundamental","pubTime":"2025-12-19 21:45","pubTimestamp":1766151919,"startTime":"0","endTime":"0","summary":"Amplia与韩国专业药物筛选公司Next&Bio签署第二项协议，探索Fak抑制剂与Kras抑制剂的联合治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATX.AU","BK7067"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}

AMPLIA THERAPEUTICS LTD

Amplia Therapeutics胰腺癌试验再获四例完全缓解 总体生存数据持续改善

Amplia与韩国专业药物筛选公司Next&Bio签署第二项协议，探索Fak抑制剂与Kras抑制剂的联合治疗

Amplia Therapeutics胰腺癌试验再获四例完全缓解总体生存数据持续改善